DPEP1 and COVID-19: Indeed, it was recently reported that neutrophil recruitment to the lungs in ARDS utilizes a unique adhesion molecule (DPEP-1), which is now being targeting in clinical trials for moderate-to-severe COVID-19 (ClinicalTrials.gov NCT04402957) (30).